Company Active LTD

Company profile

Cansense Ltd

CanSense Innovation in cancer diagnostics

Cansense Ltd is a UK company with status active founded in 2018 based in Wales.

CRN
11367637
Founded
2018
Age
8

Overview

Legal name
CANSENSE LTD
Region
Wales
Registered address
INSTITUTE OF LIFE SCIENCE 2 SWANSEA UNIVERSITY
SINGLETON PARK
SWANSEA
WALES
SA2 8PP
Insolvency history
No

Corporate ownership

Updated 07 Jul 2026 09:49

1 level 1 ultimate controller
1
Company Active LTD
Cansense Ltd
CRN 11367637
2
Direct and ultimate controller Active LTD
Cansense Group Ltd
CRN 12346893

Latest accounts

Financial period: 1 Jun 2023 to 31 May 2024

FILLETEDACCOUNTS
Turnover
Unknown
Profit / Loss
Unknown
Employees
13

Company events

Reference milestones and recent Companies House filing stream events.

6 events
30 Sep
2027

Accounts due

Accounts Due

Next accounts due date

30 May
2027

Confirmation statement due

Confirmation Due

Next confirmation statement due date

16 May
2026

Confirmation statement filed

Confirmation

Last confirmation statement made up date

31 Dec
2025

Accounts filed

Accounts

Last accounts made up date

14 Nov
2024

Termination Director Company With Name Termination Date

Officers

TM01 | Transaction MzQ0MzQ1NDY3NWFkaXF6a2N4

Published 14 Nov 2024 04:58

17 May
2018

Incorporated

Inception

Company registered at Companies House

Public funding

1 award
First funded
2023
Funded years
2023
Age at first award
5 years

Projects

2023 Collaborative R&D Lead participant

CanSense-CRC: early detection of colorectal cancer

1 Nov 2023 to 30 Apr 2025

Awarded
£200,153
Total cost £285,933

**Aim** The aim of our research project is to develop a blood test to detect the earliest stages of colorectal (bowel) cancer. Detecting cancer early allows it to be treated more simply and effectively, making it more likely to be curable. The blood test could help GPs refer patients with bowel symptoms to hospitals more effectively. The test would allow ...

Product types

Collaborative R&D